MED MEDIFAST INC
NYSE · SEC CIK 910329 · EDGAR
- Bought, last 12 months
- $1.67M 5 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 117 since 2021-07-07, latest 2026-08-28 12:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kiai Parsa | Dir | $1.42M | — |
| Chard Daniel R | COB, CEO, Dir | $178.7K | — |
| SCHLACKMAN SCOTT | Dir | $63.0K | — |
| Rose Jeffrey Matthew | Dir | — | — |
| Geary Elizabeth A. | Dir | — | — |
| MacKenzie Jonathan Barrett | VP, CAO, Fin | — | — |
| Thomas Andrea B | Dir | — | — |
| Maloney James P. | CFO | — | — |
Transactions 136
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | 2022-08-08 | MED | BROWN JEFFREY J | Dir | A - Grant | $138.78 | +9.04 | 2,354 | +0.4% | +$1,255 | |
| 2022-07-22 | 2022-07-20 | MED | Maloney James P. | CFO | F - Tax | $174.44 | -115 | 2,944 | -4% | -$20.1K | |
| 2022-06-21 | 2022-06-16 | MED | BROWN JEFFREY J | Dir | A - Grant | $0.00 | +1,580 | 2,345 | +207% | $0 | |
| 2022-06-21 | 2022-06-16 | MED | HALLQUIST CONSTANCE J. | Dir | A - Grant | $0.00 | +1,432 | 7,874 | +22% | $0 | |
| 2022-06-21 | 2022-06-16 | MED | Thomas Andrea B | Dir | A - Grant | $0.00 | +1,366 | 3,006 | +83% | $0 | |
| 2022-06-21 | 2022-06-16 | MED | Hoer Michael A. | Dir | A - Grant | $0.00 | +1,350 | 5,130 | +36% | $0 | |
| 2022-06-21 | 2022-06-16 | MED | SCHLACKMAN SCOTT | Dir | A - Grant | $0.00 | +1,448 | 7,252 | +25% | $0 | |
| I | 2022-05-11 | 2022-05-05 | MED | BROWN JEFFREY J | Dir | P - Purchase | $183.25 | +315.24 | 35.5K | +0.9% | +$57.8K |
| I | 2022-05-11 | 2022-05-05 | MED | Chard Daniel R | COB, CEO, Dir | P - Purchase | $183.25 | +431.08 | 108.6K | +0.4% | +$79.0K |
| I | 2022-04-21 | 2022-02-04 | MED | BROWN JEFFREY J | Dir | P - Purchase | $186.40 | +266.31 | 35.2K | +0.8% | +$49.6K |
| MI | 2022-04-21 | 2022-02-23+ | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | +4,328 | 108.2K | +4% | $0 |
| M | 2022-04-21 | 2022-02-23+ | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | -4,328 | 16.9K | -20% | $0 |
| I | 2022-04-21 | 2022-02-04 | MED | Chard Daniel R | COB, CEO, Dir | P - Purchase | $186.40 | +690.27 | 103.8K | +0.7% | +$128.7K |
| 2022-03-21 | 2022-03-16 | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +8,509 | 21.1K | +67% | $0 | |
| 2022-03-21 | 2022-03-17 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $180.52 | -878 | 20.3K | -4% | -$158.5K | |
| 2022-03-21 | 2022-03-17 | MED | Maloney James P. | CFO | F - Tax | $180.52 | -75 | 3,059 | -2% | -$13.5K | |
| 2022-03-21 | 2022-03-16 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +1,281 | 3,134 | +69% | $0 | |
| 2022-03-21 | 2022-03-16 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +548 | 657 | +503% | $0 | |
| 2022-03-14 | 2022-03-10 | MED | Thomas Andrea B | Dir | S - Sale | $174.31 | -1,150 | 1,640 | -41% | -$200.5K | |
| M | 2022-02-24 | 2022-02-22 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $177.06 | -3,086 | 12.6K | -20% | -$546.4K |
| 2022-01-04 | 2021-12-31 | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $209.43 | -11.5K | 28.3K | -29% | -$2.42M | |
| 2022-01-04 | 2022-01-03 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 15.7K | -44% | $0 | |
| I | 2022-01-04 | 2022-01-03 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 103.1K | +14% | $0 |
| 2022-01-04 | 2021-12-31 | MED | Chard Daniel R | COB, CEO, Dir | M - OptEx | — | +24.1K | 39.8K | +153% | — | |
| I | 2021-11-23 | 2021-11-04 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | +90.6K | 90.6K | New | $0 |
| 2021-11-23 | 2021-11-04 | MED | Chard Daniel R | COB, CEO, Dir | G - Gift | $0.00 | -90.6K | 15.7K | -85% | $0 | |
| DM | 2021-11-15 | 2021-11-11 | MED | BYRNES KEVIN G | Dir | M - OptEx | $28.92 | +12.9K | 16.1K | +410% | +$373.5K |
| D | 2021-11-15 | 2021-11-11 | MED | BYRNES KEVIN G | Dir | F - Tax | $228.45 | -6,149 | 14.9K | -29% | -$1.40M |
| MI | 2021-11-10 | 2021-11-08 | MED | BROWN JEFFREY J | Dir | P - Purchase | $231.89 | +4,200 | 32.8K | +15% | +$973.9K |
| 2021-09-15 | 2021-09-13 | MED | MacKenzie Jonathan Barrett | VP, CAO, Fin | A - Grant | $0.00 | +109 | 109 | New | $0 | |
| 2021-08-24 | 2021-08-20 | MED | BYRNES KEVIN G | Dir | S - Sale | $221.99 | -673 | 8,154 | -8% | -$149.4K | |
| I | 2021-08-10 | 2021-07-07 | MED | BROWN JEFFREY J | Dir | G - Gift | $0.00 | +1,970 | 30.6K | +7% | $0 |
| I | 2021-08-10 | 2021-08-06 | MED | BROWN JEFFREY J | Dir | P - Purchase | $286.16 | +142.14 | 30.8K | +0.5% | +$40.7K |
| 2021-08-10 | 2021-07-07 | MED | BROWN JEFFREY J | Dir | G - Gift | $0.00 | -1,970 | 765 | -72% | $0 | |
| 2021-07-22 | 2021-07-20 | MED | Maloney James P. | CFO | F - Tax | $277.00 | -115 | 1,853 | -6% | -$31.9K | |
| 2021-07-07 | 2021-07-02 | MED | HALLQUIST CONSTANCE J. | Dir | S - Sale | $285.09 | -542 | 6,442 | -8% | -$154.5K |
Purchase Sale Sale after option exercise All abbreviations